Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9124419 | 0.93 | S1PR2 (0.48) | — | |
| SCHEMBL20436811 | 0.90 | S1PR2 (0.46) | — | |
| SCHEMBL13598843 | 0.89 | SMN1; SMN2 (0.45) | ALOX15TSHRHSD17B10SLC6A5SMN1; SMN2 | |
| SCHEMBL12338366 | 0.86 | HTR2A (0.50) | SLC6A5PTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL2744248 | 0.85 | TSHR (0.50) | ALOX15TSHRHSD17B10PTGS2HTR2A | |
| SCHEMBL1200676 | 0.84 | THRA (0.44) | HTR2BSMN1; SMN2 | |
| SCHEMBL8965944 | 0.83 | HTR2A (0.62) | ALOX15TSHRHSD17B10PTGS2HTR2A | |
| SCHEMBL4291750 | 0.83 | HSD17B10 (0.60) | ALOX15TSHRHSD17B10SMN1; SMN2 | |
| SCHEMBL1201460 | 0.82 | THRA (0.45) | HTR2B | |
| SCHEMBL4864512 | 0.82 | THRA (0.45) | HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334819-A1 | A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM | ORGANOFUEL SWEDEN AB (SE) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334819-A1 | A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM | CBR1, ADH1C, AOC2 | ALOX15 1184/4885TSHR 4190/4885HSD17B10 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.